| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JINF.2011.12.005 |
| P698 | PubMed publication ID | 22198738 |
| P2093 | author name string | Hao Li | |
| Yan Gu | |||
| Xin Ding | |||
| Zhi-Hai Peng | |||
| Lin Zhong | |||
| Jun-Wei Fan | |||
| Tong-Hai Xing | |||
| Tong-Yi Men | |||
| P433 | issue | 3 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| liver transplantation | Q1368191 | ||
| P304 | page(s) | 299-310 | |
| P577 | publication date | 2011-12-14 | |
| P1433 | published in | Journal of Infection | Q6295344 |
| P1476 | title | Multidrug-resistant gram-negative bacterial infections after liver transplantation - spectrum and risk factors. | |
| P478 | volume | 64 |
| Q89474441 | A Case of Early detected Multidrug-resistant Acinetobacter baumannii Infection after Liver Transplantation |
| Q33407334 | Acinetobacter infection in a liver transplantation intensive care unit |
| Q45928333 | Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles. |
| Q26991438 | Bacterial infection after liver transplantation |
| Q39263671 | Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study |
| Q36785306 | C7 genotype of the donor may predict early bacterial infection after liver transplantation |
| Q40397644 | Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes. |
| Q36156964 | Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients. |
| Q39752203 | DCD liver transplant infection: experience from a single centre in China |
| Q41351586 | Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection |
| Q37590075 | Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran |
| Q57106909 | Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation |
| Q46852055 | Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality |
| Q35632106 | Immunity of fungal infections alleviated graft reject in liver transplantation compared with non-fungus recipients. |
| Q41486566 | Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients |
| Q42237413 | Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients |
| Q38206526 | Indications and outcomes of pancreatic surgery after liver transplantation |
| Q48144922 | Infections in liver and lung transplant recipients: a national prospective cohort |
| Q57815117 | Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions |
| Q38623310 | Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations |
| Q38216011 | Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge. |
| Q38845084 | Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections. |
| Q54290247 | Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients. |
| Q89481254 | Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria |
| Q44657782 | Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes. |
Search more.